02 9487 9111
 

Sydney Adventist Hospital
« View pages

Clinical Specialties - Cancer

Lung Cancer Clinical Trials

IMpower 

GO29438 A Phase III, Open-label, randomized study of Atezolizumab (MPDL3280A, Anti PD-L1 Antibody) in combination with Carboplatin or Cisplatin + Pemetrexed compared with Carboplatin or Cisplatin + Pemetrexed in patients who are chemotherapy-naive and have Stage IV Non-Squamous Non-Small Cell Lung Cancer

https://clinicaltrials.gov/ct2/show/NCT02657434?term=GO+29438&rank=1


NIVORAD - Recruiting

A randomised phase 2 trial of nivolumab and stereotactic ablative body radiotherapy in advanced non-small cell lung cancer, progressing after first or second line chemotherapy

https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=370098&isReview=true

Back to Top

Sydney Adventist Hospital Clinical Specialties and Services